Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies
出版年份 2014 全文链接
标题
Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies
作者
关键词
-
出版物
mAbs
Volume 2, Issue 4, Pages 379-394
出版商
Informa UK Limited
发表日期
2014-07-18
DOI
10.4161/mabs.11986
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations
- (2010) Yow-Ming C. Wang et al. Journal of Biopharmaceutical Statistics
- European Medicines Agency workshop on biosimilar monoclonal antibodies
- (2010) Janice M. Reichert et al. mAbs
- Human immunoglobulin allotypes
- (2010) Roy Jefferis et al. mAbs
- An improved trypsin digestion method minimizes digestion-induced modifications on proteins
- (2009) Da Ren et al. ANALYTICAL BIOCHEMISTRY
- Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
- (2009) Josef Vlasak et al. ANALYTICAL BIOCHEMISTRY
- Characterization of Protein Impurities and Site-Specific Modifications Using Peptide Mapping with Liquid Chromatography and Data Independent Acquisition Mass Spectrometry
- (2009) Hongwei Xie et al. ANALYTICAL CHEMISTRY
- Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7μm sorbent
- (2009) Joomi Ahn et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab
- (2009) Carola W. N. Damen et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Gearing up for follow-on biologics
- (2009) Bethan Hughes NATURE REVIEWS DRUG DISCOVERY
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab
- (2009) Charlotte Magdelaine-Beuzelin et al. Pharmacogenetics and Genomics
- The effects of alpha-helix on the stability of Asn residues: Deamidation rates in peptides of varying helicity
- (2009) Andrew A. Kosky et al. PROTEIN SCIENCE
- The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS
- (2009) Scott J. Geromanos et al. PROTEOMICS
- Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
- (2009) Royston Jefferis TRENDS IN PHARMACOLOGICAL SCIENCES
- Method to Differentiate Asn Deamidation That Occurred Prior to and during Sample Preparation of a Monoclonal Antibody
- (2008) Georgeen Gaza-Bulseco et al. ANALYTICAL CHEMISTRY
- Editorial [Hot Topic: Therapeutic Antibodies and Derivatives: From the Bench to the Clinic(Guest Editor: Alain Beck)]
- (2008) A. Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Monoclonal Antibodies as Innovative Therapeutics
- (2008) Janice Reichert CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs
- (2008) Sandipan Sinha et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Western biotechs ponder follow-on possibilities
- (2008) Emily Waltz NATURE BIOTECHNOLOGY
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now